Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis

Arthritis and Rheumatism

Volumn 54, Issue 3, 2006, Pages 864-876

  Gonzalez Rey, Elena ^a   Fernandez Martin, Amelia ^a   Chorny, Alejo ^a   Delgado, Mario ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COLLAGEN; COLLAGEN TYPE 2; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FREUND ADJUVANT; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; RECOMBINANT INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; DRUG EFFECT; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; COLLAGEN; DISEASE PROGRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED DBA; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33644925815     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21652     Document Type: Article

References (30)

1. + regulatory T cells: their common role in controlling autoimmunity, tumor and transplantation tolerance. Immunol Rev 2001;182:18-32.
2. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:816-22.
3. + T cells and the control of autoimmune disease. Curr Opin Immunol 2004;16:695-701.
4. Akbar AN, Taams LS, Salmon M, Vukmanovic-Stejic M. The peripheral generation of CD4+CD25+ regulatory T cells. Immunology 2003;109:319-25.
5. Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP. Vasoactive intestinal peptide prevents, experimental arthritis by down-regulating both autoimmune and inflammatory components of the disease. Nat Med 2001;7:563-68.
6. Abad C, Martinez C, Juarranz MG, Arranz A, Leceta J, Delgado M, et al. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterology 2003;124:961-71.
7. Keino H, Kezuka T, Takeuchi M, Yamakawa N, Hattori T, Usui M. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide. Arch Ophthalmol 2004;122:1179-84.
8. Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Martin J, Pozo D, Ganea D, et al. Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: downregulation of inflammatory and autoimmune responses. Am J Pathol. In press.
9. Delgado M, Pozo D, Ganea D. The significance of the vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 2004;56:249-90.
10. Morgan ME, Flierman R, van Duivenvoorde LM, Witteven HJ, van Ewijk W, van Laar JM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005;52:2212-21.
11. Van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004;50:2775-85.
12. Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 2000;43:617-27.
13. Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ, et al. CD25+ depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003;48:1452-60,
14. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997;100:3173-83.
15. Luross JA, Heaton T, Hirst TR, Day MJ, Williams NA. Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells. Arthritis Rheum 2002;46:1671-82.
16. Hori S, Nomura T, Sakaguchi S, Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
17. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-42.
18. + regulatory T cells. Nat Immunol 2003;4:330-6.
19. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004;34:623-30.
20. Anthony DD, Haqqi TM. Collagen-induced arthritis in mice: an animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 1999;17:240-4.
21. Thompson C, Powrie F. Regulatory T cells. Curr Opin Pharmacol 2004;4:408-14.
22. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J Exp Med 2002;196:255-60.
23. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002;196:247-53.
24. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGFβ, and IL-10. J Immunol 2004;172:5213-21.
25. Delgado M, Gonzalez-Rey E, Ganea D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J Immunol 2005;175:7311-24.
26. Chorny A, Gonzalez-Rey E, Fernandez-Martin A, Pozo D, Ganea D, Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc Natl Acad Sci U S A 2005;102:13562-7.
27. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
28. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much.ado about IDO. Trends Immunol 2003;24:242-8.
29. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001;194:847-53.
30. Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005;201:1037-44.